江苏四环生物股份有限公司 内部控制制度 第一章 总 则 第一条 为提高江苏四环生物股份有限公司（以下简称"公司"）经营管理 水平和风险防范能力，促进公司可持续发展，维护相关利益，依据《中华人民共 和国公司法》、《中华人民共和国证券法》、《中华人民共和国会计法》、《企 业内部控制基本规范》、《深圳证券交易所股票上市规则》、《深圳证券交易所 上市公司自律监管指引第 1 号——主板上市公司规范运作》及《江苏四环生物股 份有限公司章程》（以下简称"《公司章程》"），并结合公司实际情况，制定 本制度。 第二条 本制度所称内部控制，是由公司董事会、管理层和全体员工实施的、 旨在实现控制目标的过程。主要围绕内部控制环境、风险评估、控制活动、信息 与沟通、内部监督五要素内容，进行内部控制管理工作。 第三条 内部控制的目标是合理保证公司经营管理合法合规、资产安全、财 务报告及相关信息真实完整，提高经营效率和效果，促进公司实现发展战略。 第四条 建立与实施内部控制，应当遵循下列原则： （一）全面性原则。内部控制应当贯穿决策、执行和监督全过程，覆盖公司 及其所属单位的各种业务和事项。 （五）成本效益原则。内部控制应当权衡实施成本与 ...

江苏四环生物股份有限公司 信息披露事务管理制度 第一章 总 则 第一条 为规范江苏四环生物股份有限公司（以下简称"公司"）及其他信 息披露义务人的信息披露行为，加强信息披露事务管理，促进公司依法规范运作， 维护公司和投资者的合法权益，依据《中华人民共和国公司法》（以下简称《公 司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《上市公司信息披露 管理办法》、《深圳证券交易所股票上市规则》（以下简称《股票上市规则》）等有 关法律、法规和规范性文件，制定本信息披露事务管理制度。 第二条 本制度所称信息披露义务人是指公司及公司董事、高级管理人员、 股东、实际控制人，收购人，重大资产重组、再融资、重大交易有关各方等自然 人、单位及其相关人员，破产管理人及其成员，以及法律、行政法规和中国证监 会规定的其他承担信息披露义务的主体。 第三条 信息披露义务人应当及时依法履行信息披露义务，披露的信息应当 真实、准确、完整，简明清晰、通俗易懂，不得有虚假记载、误导性陈述或者重 大遗漏。 信息披露义务人披露的信息应当同时向所有投资者披露，不得提前向任何单 位和个人泄露。但是，法律、行政法规另有规定的除外。 第四条 在内幕信 ...

江苏四环生物股份有限公司 控股子公司管理制度 第一章 总则 第一条 为加强江苏四环生物股份有限公司（以下简称"公司 "）对控股 子 公司的管理，确保控股子公司规范、高效、有序的运作，合理有效地防范经 营管 理风险，保护投资者合法权益，根据《中华人民共和国公司法》（以下简 称《公 司法》）、《中华人民共和国证券法》（以下简称《证券法》）、《深 圳证券交易所股票上市规则》（以下简称《股票上市规则》）、《深圳证券交 易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法律法规、 规范性文件以及《江苏四环生物股份有限公司章程》（以下简称《公司章 程》）的有关规定，结合公司的实际情况，特制定本制度。 第二条 本制度所称控股子公司是指公司直接或间接持有其50%以上股份， 或者持有其股份在50%以下，但能够决定其董事会半数以上成员的组成，或者通 过协议或其他安排等方式能够控制或者实际控制的公司或者其他主体。 第三条 加强对控股子公司的管理，旨在建立有效的控制机制，对公司的组 织、资源、资产、投资和运作进行风险控制，提高公司整体运作效率和抗风险 能 力。 第四条 公司依据对控股子公司资产控制和上市公司规范运作要求， ...

江苏四环生物股份有限公司 委托理财管理制度 第六条 公司使用暂时闲置的募集资金委托理财，其投资产品的期限不得超 过十二个月，并满足安全性高、流动性好的要求，不得影响募集资金投资计划 正常进行，投资产品不得质押。公司委托理财应当通过募集资金专项账户或者 公开披露的产品专用结算账户实施，产品专用结算账户（如适用）不得存放非 募集资金或用作其他用途，开立或注销产品结算账户的，公司应当及时公告。 使用暂时闲置的超募资金进行现金管理的，应当说明必要性和合理性。 第三章 审批权限与执行 第一章 总 则 第一条 为规范江苏四环生物股份有限公司（以下简称"公司 "）委托理 财业务的管理，提高资金运作效率，防范委托理财决策和执行过程中的相关风 险，维护股东和公司的合法权益，根据《中华人民共和国公司法》、《中华人 民共和国证券法》、《深圳证券交易所股票上市规则》（以下简称《股票上市 规则》）、《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司 规范运作》、《深圳证券交易所上市公司自律监管指引第 7 号——交易与关联 交易》、《上市公司募集资金监管规则》等有关法律、法规、规范性文件及公 司章程的有关规定，结合公司实际情 ...

江苏四环生物股份有限公司 股 票 代 码 ： 0 0 0 5 1 8 股 票 简 称 ： * ST 四 环 公 告 编 号 ： 临 - 2 0 2 5 - 5 5 号 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 关于制定及修订公司部分治理制度的公告 | 16 | 重大信息内部报告制度 | 修订 | 否 | | --- | --- | --- | --- | | 17 | 控股子公司管理制度 | 修订 | 否 | 上述制度的制定及修订自董事会审议通过后生效，相关制度详见巨潮资讯网 （www.cninfo.com.cn）。 特此公告。 江苏四环生物股份有限公司 2025 年 10 月 24 日 2 为进一步提升江苏四环生物股份有限公司（以下简称"公司"）的规范运作 水平，根据《中华人民共和国公司法》、《深圳证券交易所股票上市规则》、《上 市公司章程指引》等相关规定，结合公司实际情况，公司拟制定及修订部分治理 制度，具体如下： | 序号 | 制度名称 | 修订情况 | 是否需提交股东会审议 | | --- | --- | --- | --- | | 1 | 总经 ...

董事和高级管理人员所持本公司股份及其变动管理规则 江苏四环生物股份有限公司 第一条 为加强对江苏四环生物股份有限公司（以下简称"公司"）董事和高 级管理人员所持本公司股份及其变动的管理，进一步明确办理程序，根据《公司 法》、《证券法》及《深圳证券交易所上市公司自律监管指引第 18 号——股东及 董事、高级管理人员减持股份》，特制定本管理规则。 第二条 公司董事、高级管理人员和证券事务代表在买卖本公司股票及其衍 生品种前，应知悉《公司法》、《证券法》等法律、法规关于内幕交易、操纵市场 等禁止行为的规定，不得进行违法违规的交易。 第三条 公司董事、高级管理人员和证券事务代表及前述人员的配偶在买卖 本公司股票及其衍生品种前，应当将其买卖计划以书面方式通知董事会秘书，董 事会秘书应当核查公司信息披露及重大事项等进展情况，如该买卖行为可能违反 《公司法》、《证券法》、《上市公司收购管理办法》、《股票上市规则》和证券交易 所其他相关规定以及公司章程等规定的，董事会秘书应当及时书面通知拟进行买 卖的董事、高级管理人员和证券事务代表，并提示相关风险。 公司董事、高级管理人员计划通过证券交易所集中竞价交易或者大宗交易方 式转让 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥112,477,006.90, representing a 124.12% increase compared to the same period last year[5] - The net profit attributable to shareholders was -¥2,598,402.92, a decrease of 26.99% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥2,772,112.03, reflecting a 57.29% increase in losses compared to the previous year[5] - The company's operating income for the year-to-date reached ¥294,374,160.07, an 88.71% increase compared to the same period last year[8] - Total operating revenue for Q3 2025 reached CNY 294,374,160.07, a significant increase from CNY 155,994,341.01 in the same period last year, representing an increase of 88.6%[15] - The net loss for Q3 2025 was CNY 13,495,557.26, compared to a net loss of CNY 15,532,421.60 in Q3 2024, showing an improvement of 13.2%[16] - Basic earnings per share (EPS) for the current period is -0.0123, compared to -0.0142 in the previous period[17] Cash Flow - The net cash flow from operating activities was ¥83,971,253.59, showing a significant increase of 11,516.57% year-on-year[5] - Cash flow from operating activities increased to 83,971,253.59 CNY from 722,857.64 CNY year-over-year, representing a significant improvement[18] - Cash inflow from operating activities totaled 254,497,038.80 CNY, up from 165,801,061.54 CNY in the previous period[17] - The net cash flow from financing activities was -¥14,197,661.13, a decrease of 117.55% compared to the previous year[8] - The net cash flow from financing activities was -14,197,661.13 CNY, worsening from -6,526,251.44 CNY year-over-year[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥509,144,403.06, down 10.27% from the end of the previous year[5] - The total assets decreased from CNY 567,402,831.84 in the previous quarter to CNY 509,144,403.06, a decline of 10.2%[15] - Total liabilities decreased from CNY 168,429,253.44 to CNY 123,666,381.92, representing a reduction of 26.6%[15] - The company's total equity decreased from CNY 398,973,578.40 to CNY 385,478,021.14, a decline of 3.8%[15] Inventory and Receivables - The company's inventory decreased by 38.24% to ¥222,259,127.65, attributed to increased sales of seedlings[8] - Inventory decreased to ¥222,259,127.65 from ¥359,876,908.61, reflecting a reduction of about 38.2%[13] - Accounts receivable rose to ¥74,290,478.79 from ¥66,065,029.10, indicating an increase of approximately 18.5%[13] - The total current assets decreased to ¥396,836,459.55 from ¥446,613,153.60, a decline of approximately 11.1%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period is 68,146[9] - The largest shareholder, Fujian Bwater Agricultural Investment Co., Ltd., holds 27.78% of shares, totaling 285,990,000 shares[9] - The company has no preferred shareholders or significant changes in the top ten shareholders participating in margin trading[10] Strategic Initiatives - The company entered into a strategic cooperation agreement with Xinyang Xinport Trade Co., Ltd., establishing a long-term supply channel for seedlings, with a total contract value of ¥26,098,107[11] - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[16] Other Financial Metrics - The company's cash and cash equivalents increased to ¥85,982,480.18 from ¥8,012,633.33 at the beginning of the period, representing a significant growth[13] - The company reported a significant increase in other income, which rose by 5,252.25% to ¥742,914.83 due to government compensation for relocation[8] - Research and development expenses amounted to CNY 21,096,501.38, slightly up from CNY 20,697,253.25, reflecting a year-over-year increase of 1.9%[15] - The company reported an investment income of CNY 1,547,446.60, compared to no investment income in the previous year[16] Audit and Compliance - The company did not undergo an audit for the third quarter financial report[19] - The company has not applied the new accounting standards for the current reporting period[19] - There were no profits reported from the merged entity prior to the merger[17]

Market Overview - As of October 17, the Shanghai Composite Index fell by 1.95%, closing at 3839.7553 points, while the Shenzhen Component Index dropped by 3.04%, closing at 12688.936 points [1]. Top Gainers in Hunan Stocks - Hunan Silver opened at 7.820 and closed at 8.040, gaining 4.28% with a highest price of 8.270 and a lowest price of 7.640, trading volume reached 338.5494 million shares [2]. - Mengjie Co. opened at 3.760 and closed at 3.860, up by 2.93%, with a highest price of 3.920 and a lowest price of 3.720, trading volume was 43.4706 million shares [2]. - Bubugao opened at 5.610 and closed at 5.740, increasing by 2.50%, with a highest price of 6.100 and a lowest price of 5.610, trading volume was 275.9286 million shares [2]. - *ST Biological opened at 8.890 and closed at 9.010, up by 1.69%, with a highest price of 9.050 and a lowest price of 8.820, trading volume reached 2.1293 million shares [2]. - *ST Gauss opened at 8.400 and closed at 8.470, gaining 1.19%, with a highest price of 8.650 and a lowest price of 8.320, trading volume was 3.6155 million shares [2]. Top Losers in Hunan Stocks - Hengli Tui opened at 0.160 and closed at 0.150, down by 11.76%, with a highest price of 0.170 and a lowest price of 0.150, trading volume reached 61.1606 million shares [3]. - Taijia Co. opened at 20.650 and closed at 19.370, decreasing by 8.20%, with a highest price of 20.890 and a lowest price of 19.360, trading volume was 14.601 million shares [3]. - Changlan Technology opened at 18.280 and closed at 16.900, down by 7.55%, with a highest price of 18.300 and a lowest price of 16.880, trading volume reached 8.7081 million shares [3]. - Jinbei Electric opened at 12.700 and closed at 11.820, decreasing by 7.51%, with a highest price of 12.740 and a lowest price of 11.770, trading volume was 44.8327 million shares [3]. - Aoshikang opened at 39.800 and closed at 37.070, down by 6.86%, with a highest price of 39.800 and a lowest price of 36.900, trading volume reached 5.6638 million shares [3].

Core Points - The Shanghai Composite Index closed at 3933.97 points, above the six-month moving average, with a gain of 1.32% [1] - The total trading volume of A-shares reached 26,718.18 billion yuan, with 174 A-shares breaking through the six-month moving average [1] Summary by Category Market Performance - The Shanghai Composite Index increased by 1.32%, closing above the six-month moving average at 3933.97 points [1] - A total trading volume of 26,718.18 billion yuan was recorded for A-shares [1] Individual Stock Performance - Notable stocks that broke through the six-month moving average include: - Zhongya Co., with a price increase of 19.97% and a deviation rate of 14.85% [1] - Zhongzhou Special Materials, with a price increase of 19.99% and a deviation rate of 14.75% [1] - Changhong Technology, with a price increase of 11.65% and a deviation rate of 10.37% [1] - Other stocks with smaller deviation rates that just crossed the six-month line include: - China Electric Environmental Protection, Xiamen Port Authority, and Qianhe Flavoring [1]

Core Insights - The Shanghai Composite Index closed at 3931.07 points, above the six-month moving average, with a gain of 1.24% [1] - The total trading volume of A-shares reached 172.69 billion yuan, with 138 A-shares breaking through the six-month moving average [1] Summary of Key Stocks - The stocks with the largest deviation rates above the six-month moving average include: - Zhongya Co., Ltd. (300512) with a deviation rate of 14.85% and a daily increase of 19.97% [1] - Zhongzhou Special Materials (300963) with a deviation rate of 14.75% and a daily increase of 19.99% [1] - Guoguang Electric (688776) with a deviation rate of 7.63% and a daily increase of 20.00% [1] - Other notable stocks with smaller deviation rates include: - CNOOC Services (small deviation rate, just above the six-month line) [1] - Fengfan Co., Ltd. (small deviation rate, just above the six-month line) [1] - Haixiang Pharmaceutical (small deviation rate, just above the six-month line) [1] Trading Activity - The trading turnover rates for the top stocks with significant price movements were as follows: - Zhongya Co., Ltd. (7.56%) [1] - Zhongzhou Special Materials (25.39%) [1] - Guoguang Electric (6.51%) [1]